# Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma

> **NCT05410301** · NA · WITHDRAWN · sponsor: **Varun Monga, MD**

## Conditions studied

- Glioblastoma
- Recurrent Glioblastoma

## Interventions

- **DEVICE:** Static Magnetic and Electric (sBE) device
- **DRUG:** Lomustine
- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT05410301
- **Lead sponsor:** Varun Monga, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-04
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI leaving institution
- **Last updated:** 2023-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05410301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05410301, "Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT05410301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*